Follow Vertex Pharmaceuticals Inc / Ma. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
19 Stories, 16 about Vertex Pharmaceuticals Inc / Ma 76 approved Programs 217 recruiting Registered trials 8-K Nov 16 Latest SEC filing Nov 16 Latest story
Timeline 16 Pipeline 7 Trials 21
Pipeline by stage
Approved 6 Phase 3 1
Phase 3 primary completions, next 6 months
All trials by completion date Details
Headquarters Boston, MA Incorporated Massachusetts Industry Pharmaceutical Preparations Also known as Alpine Immune Sciences, Semma Therapeutics, Vertex Pharmaceuticals Incorporated, ViaCyte, VRTX How the company describes itself Vertex Pharmaceuticals develops small molecules and biologics for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain. Its mid- and late-stage pipeline includes programs for IgA nephropathy, APOL1-mediated kidney disease, neuropathic pain, type 1 diabetes, and other serious conditions. Headquartered in Massachusetts. source